Cosette Pharmaceuticals Expands Branded Portfolio with SYMPAZAN® and Other Asset Acquisition from Assertio
Cosette Pharmaceuticals Broadens Branded Portfolio with Acquisition of SYMPAZAN® and Additional Assets from Assertio Cosette Pharmaceuticals has announced the successful closing of a strategic acquisition that significantly expands its branded…
Assertio to Be Acquired by Garda Therapeutics in Strategic Deal
Assertio Enters Definitive Agreement for Acquisition by Garda Therapeutics Assertio Holdings Inc. has announced a transformative set of transactions that will significantly reshape the company’s structure and deliver immediate value…
TAE Life Sciences Reports Breakthrough BNCT Data Showing Durable Tumor Control and Systemic Immune Response
TAE Life Sciences Highlights Breakthrough BNCT Research Showing Sustained Tumor Control and Systemic Immune Effects TAE Life Sciences has announced the publication of new preclinical research in ACS Pharmacology &…
Pilatus Biosciences to Present Sex-Specific CD36 Antibody Data in Colorectal Cancer at AACR 2026
Pilatus Biosciences to Showcase New Data on Sex-Specific Efficacy of CD36-Targeting Antibody in Colorectal Cancer at AACR 2026 Pilatus Biosciences has announced that it will present new preclinical findings at…
Lincotek Names New Global General Manager for Medical Division
Lincotek Announces Appointment of New Global General Manager for Its Medical Division Lincotek has announced the appointment of Gianluca Fioravanti as Global General Manager of its Medical Division, marking a…
Virica Biotech and FUJIFILM Biosciences Partner to Advance AAV Production Enhancers Under Canada–Japan Program
Virica Biotech and FUJIFILM Biosciences Team Up to Advance AAV Production Enhancers Through Canada–Japan Co-Innovation Initiative Virica Biotech, a biotechnology firm focused on improving viral vector manufacturing through its proprietary…
Humana Inc. and CPESN USA Launch Value-Based Pharmacist Rewards Program to Enhance Chronic Care
Humana Inc. Healthy Horizons in Ohio and CPESN USA Introduce Value-Based Pharmacist Quality Rewards Program to Improve Chronic Disease Care Humana Inc., through its Medicaid plan Humana Healthy Horizons in…
Shionogi & Co., Ltd. Awarded U.S. Government Contract via BARDA Project BioShield for Drug-Resistant Bacterial Preparedness
Shionogi & Co., Ltd. Secures U.S. Government Contract via BARDA Project BioShield to Strengthen Preparedness Against Drug-Resistant Bacterial Threats Shionogi & Co., Ltd. has announced that its U.S.-based subsidiary, Shionogi…
Adagio Medical Receives U.S. Food and Drug Administration IDE Approval to Evaluate Next-Generation vCLAS® Ventricular Ablation System
Adagio Medical Secures U.S. Food and Drug Administration IDE Approval to Study Its Next-Generation vCLAS® Ventricular Ablation System Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio”), a medical technology company focused…
Cognito Therapeutics Partners with Initiative to Replace “Dementia” Terminology Across Communications
Cognito Therapeutics Collaborates with Initiative to Replace the “D-Word,” Committing to Remove “Dementia” from All Communications Cognito Therapeutics, a late clinical-stage neurotechnology company focused on developing non-invasive therapies for neurodegenerative…
ReAlta Life Sciences Secures $40M Financing to Advance Pegtarazimod Phase 2 Program in HIE
ReAlta Life Sciences Completes Oversubscribed $40M Financing to Support Pegtarazimod Phase 2 Development in Hypoxic Ischemic Encephalopathy (HIE) ReAlta Life Sciences Inc. (“ReAlta”), a clinical-stage biopharmaceutical company focused on targeting…
United Therapeutics Corporation Receives U.S. Food and Drug Administration RMAT Designation for miroliverELAP® in Acute Liver Failure
United Therapeutics Corporation Receives U.S. Food and Drug Administration Regenerative Medicine Advanced Therapy (RMAT) Designation for miroliverELAP® in the Treatment of Acute Liver Failure United Therapeutics Corporation (Nasdaq: UTHR), a…